LisaRochelleTannockMD
Endocrinology • Lexington, KYDiabetes, Lipid Metabolism
Professor of Internal Medicine Associate Provost for Faculty Advancement
Dr. Tannock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2195 Harrodsburg Rd
Lexington, KY 40504Phone+1 859-323-5821Fax+1 859-257-7899- Is this information wrong?
Summary
- Dr Tannock, MD is Associate Provost for Faculty Advancement, and a Professor in the Division of Endocrinology, Diabetes and Metabolism at the University of Kentucky. She obtained her MD and Internal Medicine training at the University of Toronto, Canada, then completed a fellowship in Metabolism, Endocrinology and Nutrition at the University of Washington. She is a physician-scientist with administrative, clinical, educational and research activities. As a clinician, Dr Tannock has a primary focus on the care of individuals with or at risk for diabetes, hyperlipidemia and cardiovascular disease, as well as directing a program providing gender affirming hormone therapy. Her research activity is focused on the role of inflammation and lipid metabolism in diabetes associated cardiovascular diseases. She has served as a mentor to numerous trainees at all levels of training and the majority of her publications are co-authored by these trainees. In her administrative role Dr. Tannock oversees faculty issues, development, recruitment and retention, and leadership training across the campus.
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 2000
University of Toronto Faculty of MedicineClass of 1994
Certifications & Licensure
KY State Medical License 2004 - 2025- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- Antisense oligonucleotide targeting hepatic Serum Amyloid A limits the progression of angiotensin II-induced abdominal aortic aneurysm formation.Preetha Shridas, Ailing Ji, Andrea C Trumbauer, Victoria P Noffsinger, Luke W Meredith, Frederick C de Beer, Adam E Mullick, Nancy R Webb, Dennis G Karounos, Lisa R Ta...> ;Atherosclerosis. 2024 Apr 1
- Promoting a more diverse and inclusive research workforce through the research scholars program.Nancy E Schoenberg, Jimmy Robinson, Margaret McGladrey, Lisa A Cassis, Darwin Conwell, Kevin J Pearson, Lisa R Tannock, Donna Wilcock, Stephanie White> ;BMC Medical Education. 2024 Jan 30
- Deficiency of Acute-Phase Serum Amyloid A Exacerbates Sepsis-Induced Mortality and Lung Injury in Mice.Ji, A., Trumbauer, A., Noffsinger, V., Meredith, L., Dong, B., Wang, Q., Guo, L., Li, X., De Beer, F., Webb, N., Starr, M., Waters, C., Shridas, P., Tannock, L.> ;International Journal of Molecular Sciences. 2023 Dec 15
- Join now to see all
Press Mentions
- Adults with Endocrine Disorders Have an Increased Risk of Heart DiseaseOctober 23rd, 2020
Taster’s Choice: The Endocrinology of the TongueMarch 9th, 2018
U.S. News & World Report Ranks UK Chandler Hospital Best in the State, UK HealthCare Specialty Services Nationally RankedAugust 8th, 2017- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
UK HealthCare Good Samaritan HospitalLexington, Kentucky
University of Kentucky Albert B. Chandler HospitalLexington, Kentucky
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
